- ASSISTANT PROFESSOR Radiology
BS, Peking University
PhD, Washington University in St. Louis
Dr. Junqian (Gordon) Xu received his PhD degree from the Biomedical Magnetic Resonance Lab (BMRL) at Washington University in St. Louis in 2007. He completed his postdoctoral training in the Multiple Sclerosis Center at Washington University School of Medicine. In 2010, Dr. Xu joined the WU-Minn consortium of the Human Connectome Project (HCP) and had worked on multiband EPI sequence development at the Center for Magnetic Resonance Research (CMRR), University of Minnesota for two years before joining Mount Sinai in 2012.
RSNA Scholar Award
Radiological Society of North America
Doris P. and Harry I. Wexler Prize for multiple sclerosis and eye disease research
Washington University School of Medicine
M. S. Moore Young Investigator Award Finalist
International Society for Magnetic Resonance in Medicine
2007 - 2010
National Multiple Sclerosis Society Postdoctoral Fellowship
2005 - 2007
Department of Defense Predoctoral Fellowship
Our lab is interested in developing quantitative functional magnetic resonance (MR) techniques and their applications in neurometablism and neuropathophysiology. We are working on:
- fast MR imaging and spectroscopy methods for quantitative neuroimaging.
- reliable MR techniques for functional and structural assessment of spinal cord, nerve roots, optic nerve, and retina.
- a “Connectomic” imaging approach for tissue recovery, repair and clinical outcomes in multiplesclerosis.
There is an immediate opening of a postdoc position in our lab.
Xu J, Sun SW, Naismith RT, Snyder AZ, Cross AH, Song SK. Assessing optic nerve pathology with diffusion MRI: from mouse to human. NMR in Biomedicine 2008 Nov; 21(9): 928-40.
Naismith* RT, Xu* J, Tutlam NT, Snyder A, Benzinger T, Shimony J, Shepherd J, Trinkaus K, Cross AH, Song SK. Disability in optic neuritis correlates with diffusion tensor-derived directional diffusivities. Neurology 2009 Feb; 72(7): 589-94.
Xu J, Humphrey PA, Kibel AS, Snyder AZ, Narra VR, Ackerman JJ, Song SK. Magnetic resonance diffusion characteristics of histologically defined prostate cancer in humans. Magnetic Resonance in Medicine 2009 Apr; 61(4): 842-50.
Naismith* RT, Xu* J, Tutlam NT, Scully PT, Trinkaus K, Snyder AZ, Song SK, Cross AH. Increased diffusivity in acute multiple sclerosis lesions predicts risk of black hole. Neurology 2010 May; 74(21): 1694-701.
Naismith* RT, Xu* J, Tutlam NT, Trinkaus K, Cross AH, Song SK. Radial diffusivity in remote optic neuritis discriminates visual outcomes. Neurology 2010 May; 74(21): 1702-10.
Naismith* RT, Xu* J, Tutlam NT, Lancia S, Trinkaus K, Song SK, Cross AH. Diffusion tensor imaging in acute optic neuropathies: predictor of clinical outcomes. Archives of Neurology 2012 Jan; 69(1): 65-71.
Smith SM, Miller KL, Moeller S, Xu J, Auerbach EJ, Woolrich MW, Beckmann CF, Jenkinson M, Andersson J, Glasser MF, Van Essen DC, Feinberg DA, Yacoub ES, Ugurbil K. Temporally-independent functional modes of spontaneous brain activity. Proceedings of the National Academy of Sciences of the United States of America 2012 Feb; 109(8): 3131-6.
Klawiter EC, Xu J, Naismith RT, Benzinger TL, Shimony JS, Lancia S, Snyder AZ, Trinkaus K, Song SK, Cross AH. Increased radial diffusivity in spinal cord lesions in neuromyelitis optica compared with multiple sclerosis. Multiple Sclerosis 2012 Sep; 18(9): 1259-68.
Van Essen DC, Ugurbil K, Auerbach E, Barch D, Behrens TE, Bucholz R, Chang A, Chen L, Corbetta M, Curtiss SW, Della Penna S, Feinberg D, Glasser MF, Harel N, Heath AC, Larson-Prior L, Marcus D, Michalareas G, Moeller S, Oostenveld R, Petersen SE, Prior F, Schlaggar BL, Smith SM, Snyder AZ, Xu J, Yacoub E. The Human Connectome Project: A data acquisition perspective. NeuroImage 2012 Oct; 62(4): 2222-31.
Xu J, Shimony JS, Klawiter EC, Snyder AZ, Trinkaus K, Naismith RT, Benzinger TL, Cross AH, Song SK. Improved in vivo diffusion tensor imaging of human cervical spinal cord. NeuroImage 2013 Feb; 67(15): 64-76.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Xu during 2012 and/or 2013. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
- Biomedical Systems
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.
CSM aka Primary Care Building Floor 1 Room 109
1470 Madison Avenue
New York, NY 10029